Showing results (1181-1190 of 1,252) with videos related to
Sort By:
Pageof 126
Nature Communications|June 13, 2015
TCF12 is mutated in anaplastic oligodendrogliomaKarim Labreche, Iva Simeonova, Aurélie Kamoun, et al.Nature Communications|December 22, 2019
scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapyJennifer Karin Ocasio, Benjamin Babcock, Daniel Malawsky, et al.Atherosclerosis|July 31, 2018
Ldlr-/- and ApoE-/- mice better mimic the human metabolite signature of increased carotid intima media thickness compared to other animal models of cardiovascular diseaseJean Sébastien Saulnier-Blache, Rory Wilson, Kristaps Klavins, et al.Autoimmunity Reviews|June 10, 2018
Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus: Are they different entities?Cristina Belizna, Ljudmila Stojanovich, Jan Willem Cohen-Tervaert, et al.Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|September 2, 2022
Organ donation by Maastricht-III pediatric patients: Recommendations of the Groupe Francophone de Réanimation et Urgences Pédiatriques (GFRUP) and Association des Anesthésistes Réanimateurs Pédiatriques d'Expression Française (ADARPEF). Part II: Specific organizational and technical considerationsS Dauger, S Blanot, A Deho, et al.Diabetes Care|December 28, 2023
Insulin Secretion, Sensitivity, and Kidney Function in Young Individuals With Type 2 DiabetesPetter Bjornstad, Ye Ji Choi, Carson Platnick, et al.Nature Medicine|August 21, 2007
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapyLionel Apetoh, François Ghiringhelli, Antoine Tesniere, et al.Cancer Reports (Hoboken, N.J.)|March 31, 2022
A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastomaJacqueline M Kraveka, Elizabeth C Lewis, Genevieve Bergendahl, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2011
Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC] project--part 1)Michèle Beau-Faller, Armelle Degeorges, Estelle Rolland, et al.Acta Neuropathologica Communications|December 20, 2023
miRNA-211 maintains metabolic homeostasis in medulloblastoma through its target gene long-chain acyl-CoA synthetase 4Menglang Yuan, Iqbal Mahmud, Keisuke Katsushima, et al.Pageof 126